Cargando…
Replisome genes regulation by antitumor miR‐101‐5p in clear cell renal cell carcinoma
Analysis of microRNA (miRNA) regulatory networks is useful for exploring novel biomarkers and therapeutic targets in cancer cells. The Cancer Genome Atlas dataset shows that low expression of both strands of pre‐miR‐101 (miR‐101‐5p and miR‐101‐3p) significantly predicted poor prognosis in clear cell...
Autores principales: | Yamada, Yasutaka, Nohata, Nijiro, Uchida, Akifumi, Kato, Mayuko, Arai, Takayuki, Moriya, Shogo, Mizuno, Keiko, Kojima, Satoko, Yamazaki, Kazuto, Naya, Yukio, Ichikawa, Tomohiko, Seki, Naohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156888/ https://www.ncbi.nlm.nih.gov/pubmed/31975570 http://dx.doi.org/10.1111/cas.14327 |
Ejemplares similares
-
The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma
por: Goto, Yusuke, et al.
Publicado: (2016) -
Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2017) -
Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
por: Arai, Takayuki, et al.
Publicado: (2018) -
Impact of novel oncogenic pathways regulated by antitumor miR‐451a in renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018) -
Regulation of antitumor miR‐144‐5p targets oncogenes: Direct regulation of syndecan‐3 and its clinical significance
por: Yamada, Yasutaka, et al.
Publicado: (2018)